Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DGAP-PVR: Bayer Aktiengesellschaft: Release -2-

06/10/2021 | 03:41am EDT
 The Goldman Sachs Group,                             %                                      %                       % 
 Inc. 
 
 GS Finance Corp.                                     %                                      %                       % 
 
 -                                                    %                                      %                       % 
 
 The Goldman Sachs Group,                             %                                      %                       % 
 Inc. 
 
 Goldman Sachs & Co. LLC                              %                                      %                       % 
 
 -                                                    %                                      %                       % 
 
 The Goldman Sachs Group,                             %                                      %                       % 
 Inc. 
 
 IMD Holdings LLC                                     %                                      %                       % 
 
 United Capital Financial                             %                                      %                       % 
 Partners, Inc. 
 
 United Capital Financial                             %                                      %                       % 
 Advisers, LLC 
 
 -                                                    %                                      %                       % 
 
 The Goldman Sachs Group,                             %                                      %                       % 
 Inc. 
 
 Goldman Sachs (UK) L.L.C.                            %                                      %                       % 
 
 Goldman Sachs Group UK                               %                                      %                       % 
 Limited 
 
 Goldman Sachs International                          %                                      %                       % 
 9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting: 
 
 
  Proportion of voting rights Proportion of instruments Total of both 
 
                            %                         %             % 
 10. Other explanatory remarks: 
 
 
 
 Date 
 
 
 09 Jun 2021 
 ----------------------------------------------------------------------------------------------------------------------- 

2021-06-10 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de -----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      Bayer Aktiengesellschaft 
              Kaiser-Wilhelm-Allee 1 
              51373 Leverkusen 
              Germany 
Internet:     www.bayer.com 
 
End of News   DGAP News Service 
=------------ 

1206341 2021-06-10

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1206341&application_name=news 
 

(END) Dow Jones Newswires

June 10, 2021 03:40 ET (07:40 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
BAYER AG -1.35% 52.75 Delayed Quote.9.54%
DJ INDUSTRIAL -1.58% 33290.08 Delayed Quote.10.51%
SSP GROUP PLC -4.27% 304.7 Delayed Quote.10.94%
THE GOLDMAN SACHS GROUP, INC. -3.50% 348.83 Delayed Quote.32.28%
All news about BAYER AG
06/18PRESS RELEASEá : BioNTech Announces First Patient Dosed in Phase 2 Clinical Tria..
DJ
06/18CureVac Could Allow Manufacturing Partners To Produce Rival Vaccines
MT
06/17SECTOR UPDATE : Health Care Stocks Add to Afternoon Gains
MT
06/17CureVac may let contractors make rival vaccines if own shot fails -CEO
RE
06/17SECTOR UPDATE : Health Care Stocks Maintaining Modest Thursday Advance
MT
06/17CureVac may let contractors make rival vaccines if own shot fails - CEO
RE
06/17CUREVAC Ná : Reports Disappointing Study Results for COVID-19 Vaccine, Driving S..
MT
06/17Bayer to Continue to Work With Curevac After Covid-19 Study Disappointment
DJ
06/16CUREVAC Ná : COVID-19 Vaccine Only 47% Effective in Mid-Stage Study
MT
06/16CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
RE
More news
Financials
Sales 2021 41 349 M 49 051 M 49 051 M
Net income 2021 3 593 M 4 263 M 4 263 M
Net Debt 2021 38 658 M 45 860 M 45 860 M
P/E ratio 2021 15,4x
Yield 2021 3,84%
Capitalization 51 823 M 61 438 M 61 477 M
EV / Sales 2021 2,19x
EV / Sales 2022 2,07x
Nbr of Employees 99 329
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 64,63 €
Last Close Price 52,75 €
Spread / Highest target 61,1%
Spread / Average Target 22,5%
Spread / Lowest Target -50,8%
EPS Revisions
Managers and Directors
NameTitle
Werner Baumann Chairman-Management Board
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG9.54%61 438
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795